Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Sandoz Group Ag (0SAN) Share Price

Price 58.22937 on 12-12-2025 at 19:15:10
Change 0.00 0%
Buy 0.00
Sell 0.00
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Unknown 1,459.00 at 57.91399
Day's Volume: 102,502
Last Close: 58.22937
Open: 0.00
ISIN: CH1243598427
Day's Range 0.00 - 0.00
52wk Range: 30.61 - 59.22328
Market Capitalisation: -
VWAP: 58.23783
Shares in Issue: 430.70m

Sector: Medicine and Biotech

Sandoz Group Ag (0SAN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 1,459 57.91399 OTC Trade
 18:28:35 - 12-Dec-25
Unknown* 20,477 57.54 OTC Trade
 17:47:36 - 12-Dec-25
Unknown* 111 58.22937 SI Trade
Negotiated Trade
 17:32:14 - 12-Dec-25
Unknown* 20 57.5315 OTC Trade
 17:29:25 - 12-Dec-25
Unknown* 228 57.5314 OTC Trade
 17:28:36 - 12-Dec-25
Unknown* 186 57.5313 OTC Trade
 17:28:35 - 12-Dec-25
Unknown* 1,008 57.5314 OTC Trade
 17:28:35 - 12-Dec-25
Unknown* 269 57.53425 OTC Trade
 17:24:54 - 12-Dec-25
Unknown* 378 58.59635 OTC Trade
 17:12:28 - 12-Dec-25
Unknown* 108 58.26463 OTC Trade
 17:07:50 - 12-Dec-25
See more Sandoz Group Ag trades

Sandoz Group Ag (0SAN) Share Price History

Time period:
to
Date Open High Low Close Volume
12th Dec 2025 (Fri) 58.22937 58.22937 58.22937 58.22937 102,502
11th Dec 2025 (Thu) 59.22328 59.22328 59.22328 59.22328 1,796,823
10th Dec 2025 (Wed) 58.94815 58.94815 58.94815 58.94815 105,716
9th Dec 2025 (Tue) 59.15907 59.15907 59.15907 59.15907 137,075
8th Dec 2025 (Mon) 59.01502 59.01502 59.01502 59.01502 158,174
5th Dec 2025 (Fri) 57.78239 57.78239 57.78239 57.78239 115,165
4th Dec 2025 (Thu) 57.11553 57.11553 57.11553 57.11553 126,375
3rd Dec 2025 (Wed) 57.36533 57.36533 57.36533 57.36533 65,003
2nd Dec 2025 (Tue) 56.94395 56.94395 56.94395 56.94395 227,883
1st Dec 2025 (Mon) 56.55679 56.55679 56.55679 56.55679 10,007
28th Nov 2025 (Fri) 56.59938 56.59938 56.59938 56.59938 198,238
27th Nov 2025 (Thu) 56.15204 56.15204 56.15204 56.15204 157,659
26th Nov 2025 (Wed) 56.19468 56.19468 56.19468 56.19468 136,951
25th Nov 2025 (Tue) 55.70977 55.70977 55.70977 55.70977 606,485
24th Nov 2025 (Mon) 55.60 55.60 55.60 55.60 1,368,232
21st Nov 2025 (Fri) 53.95725 53.95725 53.95725 53.95725 70,320
20th Nov 2025 (Thu) 54.23213 54.23213 54.23213 54.23213 22,039
19th Nov 2025 (Wed) 53.94864 53.94864 53.94864 53.94864 76,551
18th Nov 2025 (Tue) 54.01004 54.01004 54.01004 54.01004 52,507
17th Nov 2025 (Mon) 54.96517 54.96517 54.96517 54.96517 72,202
14th Nov 2025 (Fri) 54.42514 54.42514 54.42514 54.42514 47,073
13th Nov 2025 (Thu) 55.18063 55.18063 55.18063 55.18063 98,446
See more Sandoz Group Ag price history

Sandoz Group Ag (0SAN) Regulatory News

Date Source Headline
12th Aug 2025 6:00 am GNW Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations
7th Aug 2025 6:00 am GNW Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
30th Jul 2025 6:15 am GNW Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France
1st Jul 2025 1:56 pm GNW Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
2nd Jun 2025 6:00 am GNW Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
21st May 2025 4:30 pm GNW Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars
30th Apr 2025 6:00 am GNW Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed
29th Apr 2025 4:00 pm GNW Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications
15th Apr 2025 12:50 pm GNW Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG
14th Apr 2025 3:00 pm GNW [Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
See more Sandoz Group Ag regulatory news
FTSE 100 Latest
Value9,649.03
Change-54.13

Login to your account

Forgot Password?

Not Registered